Retrospective evaluation of adverse reactions after subcutaneous allergen-specific immunotherapy in children with house dust mite allergy
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 10 (5) , 675-680
Abstract
OBJECTIVE: Although it is accepted as an effective and safe treatment way, side effects can be observed as a result of subcutaneous immunotherapy (SCIT). In our study, it was aimed to evaluate the local and systemic reactions in children after SCIT and the factors that may be associated with these reactions.METHODS: Our study included 138 house dust mite allergic patients with asthma and/or allergic rhinitis who underwent SCIT in the Pediatric Allergy and Immunology Outpatient Clinic between November 2013 and April 2022. Sociodemographic, clinical, laboratory features, and development of adverse reactions after SCIT were analyzed from patient files.RESULTS: The median age of 138 patients was 9.0 years. About 56.5% (n=78) were male, 43.5% (n=60) were female. Of the patients, 55.1% (n=76) had asthma and allergic rhinitis. A total of 7366 SCIT injections were administered to all patients in our clinic. The total number of observed adverse reaction was 118. 50.7% of the patients (n=70) experienced at least one adverse reaction after SCIT. The rate of development of adverse reactions per injection was 1.6% (local: 1.0%, large local: 0.1%, systemic: 0.5%).CONCLUSION: Although serious systemic reactions and death were not observed in our patients; care should be taken in terms of the development of adverse reactions during SCIT in children.Keywords
This publication has 17 references indexed in Scilit:
- Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in ChildrenFrontiers in Pediatrics, 2017
- World Allergy Organization Systemic Allergic Reaction Grading System: Is a Modification Needed?The Journal of Allergy and Clinical Immunology: In Practice, 2017
- Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in TurkeyInternational Journal of Pediatric Otorhinolaryngology, 2016
- Clinical contraindications to allergen immunotherapy: an EAACI position paperAllergy, 2015
- Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from TurkeyImmunopharmacology and Immunotoxicology, 2015
- Assessing the safety of subcutaneous immunotherapy dose adjustmentsAnnals of Allergy, Asthma & Immunology, 2010
- Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading SystemJournal of Allergy and Clinical Immunology, 2010
- A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergyClinical & Experimental Allergy, 2009
- Allergen immunotherapy: A practice parameter second updateJournal of Allergy and Clinical Immunology, 2007
- Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paperJournal of Allergy and Clinical Immunology, 1998